Induction of interleukin‐10 and suppressor of cytokine signalling‐3 gene expression following peptide immunotherapy

Abstract

HLA-DR-based T cell epitopes modify surrogate markers associated with successful immunotherapy and induction of immune regulation, supporting the concept that this form of treatment may be efficacious in human allergic disease.